الصفحة الرئيسية>>Peptides>>Adrenomedullin (AM) (13-52), human

Adrenomedullin (AM) (13-52), human

رقم الكتالوجGC32622

Adrenomedullin (AM) (13-52) ، الإنسان عبارة عن 40 ببتيد من الأحماض الأمينية ، يعمل كعامل موسع للأوعية يعتمد على البطانة

Products are for research use only. Not for human use. We do not sell to patients.

Adrenomedullin (AM) (13-52), human التركيب الكيميائي

Cas No.: 154765-05-6

الحجم السعر المخزون الكميّة
1mg
129٫00
متوفر
5mg
405٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Adrenomedullin (AM) (13-52), human is a 40 amino acid peptide, which acts as an endothelium-dependent vasodilator agent.

The effects of Adrenomedullin (AM) (13-52), human [hADM-(13-52)] are investigated in the rat pulmonary vascular bed and in isolated rings from the rat pulmonary artery (PA). Under conditions of controlled blood flow and constant left atrial pressure when tone is increased with U-46619, injection of hADM-(13-52) produces dose-related decreases in lobar arterial pressure. hADM-(13-52) modulates receptor-mediated, but not voltage-dependent, pulmonary vascular contraction by influencing Ca2+ influx[1].

[1]. Gumusel B, et al. Analysis of responses to adrenomedullin-(13-52) in the pulmonary vascular bed of rats. Am J Physiol. 1998 Apr;274(4 Pt 2):H1255-63.

مراجعات

Review for Adrenomedullin (AM) (13-52), human

Average Rating: 5 ★★★★★ (Based on Reviews and 29 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Adrenomedullin (AM) (13-52), human

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.